Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, M-H
Right arrow Articles by Liou, L-b
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, M-H
Right arrow Articles by Liou, L-b
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 12, No. 10, 747-753 (2003)
DOI: 10.1191/0961203303lu459oa

Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis

M-H Tsai

Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan County, Taiwan

W-P Tsai

Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan County, Taiwan

S-T Liao

Division of Rheumatology and Immunology, Department of Internal Medicine, Taipei Municipal Jen-Ai Hospital, Taipei city, Taiwan

L-b Liou

Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan County, Taiwan, b890121{at}adm.cgmh.org.tw

The goals of this study are to determine the frequency of anticardiolipinantibodies (ACA) in patients with various diseases and to evaluate the clinical significance of ACA in Taiwan. We collected 690 patients from ACA laboratory records. They were divided into eight groups in order to compare ACA percentages. Positive rates of ACA in different disease groups were below 20%, except for 38.2% in autoimmune diseases with vascular thrombosis. Compared with old stroke, the ACA positivity in young stroke was not significantly different (P 0.482). The positive percentage of lupus anticoagulant (LA) (2.86%) was lower than that of ACA (15.66%) in young stroke (P 0.015). Among patients with pregnancy loss or prematurity, the ACA positivity in lupus patients (44.44%) was higher than without lupus (9.76%; P 0.01). The prevalence of ACA is higher in patients with vascular thrombosis complicated by autoimmune diseases than with thrombosis alone in Taiwan. Young and old stroke do not differ in ACA positivity. Moreover, ACA is more prevalent than LA for young stroke related coagulation.The ACA positivity for pregnancy loss or prematurity is very low in Taiwan. In summary, this is the first report on the frequency of ACA and other coagulation factors in various diseases in Taiwan.

Key Words: anticardiolipin antibodies • autoimmune diseases • pregnancy loss • stroke • vascular thrombosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
H. S. Chen, W. P. Tsai, H. S. Leu, H. H. Ho, and L. B. Liou
Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review
Rheumatology, March 1, 2007; 46(3): 539 - 544.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu
The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 69 - 76.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu
The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 203 - 210.
[Abstract] [PDF]